Novogen Limited Stock Australian S.E.
Equities
AU000000NRT0
Biotechnology & Medical Research
Sales 2022 | 10K 6.62K 9.1K | Sales 2023 | 555 367.14 504.8 | Capitalization | 39.72M 26.27M 36.12M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.88M -21.83M | Net income 2023 | -20M -13.23M -18.19M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.87M 6.7M | Net cash position 2023 | 3.44M 2.28M 3.13M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Novogen Limited
1st Jan change | Capi. | |
---|---|---|
+38.66% | 52.85B | |
+35.54% | 38.24B | |
-7.81% | 38.87B | |
-10.77% | 26.79B | |
+11.77% | 26.16B | |
-17.82% | 19.9B | |
+35.09% | 13.18B | |
+29.17% | 12.24B | |
-3.05% | 11.79B |